| Giant Cell Tumor studied in …STUDIED_INderived52 of 52show fewer |
|---|
| → studied in | NCT07832747Phase 2 · not yet recruiting A Study of DCC-3014 to Evaluate the Efficacy, Safety, and Pharmacokinetics in Subjects With TGCT · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07499362Phase 2 · recruiting Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER) · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05463796recruiting InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06239272Phase 1/Phase 2 · recruiting NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) · condition mapped ALIAS · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Soft Tissue | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07075471recruiting MOVE: Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07707882Phase 2 · not yet recruiting Neoadjuvant Pimicotinib Combined With Surgery Versus Upfront Surgery for Diffuse Tenosynovial Giant Cell Tumor · condition mapped ALIAS · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor, Diffuse Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04488822Phase 3 · active not recruiting A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03069469Phase 1/Phase 2 · active not recruiting Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor · condition mapped ALIAS · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor, Diffuse Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04703322Phase 2 · completed A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07609277recruiting TRACP-5b for Diagnosis and Follow-up of Giant Cell Tumor of Bone · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03449108Phase 2 · active not recruiting LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05804045Phase 3 · active not recruiting Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER) · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03295981Phase 3 · recruiting Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059262Phase 3 · active not recruiting Study of Vimseltinib for Tenosynovial Giant Cell Tumor · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04192344Phase 1 · recruiting A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01207492Phase 2 · completed Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor · condition mapped ALIAS · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor, Diffuse Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07315828Phase 4 · recruiting Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Giant Cell Tumor of Bone Surgery · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07315841Phase 4 · recruiting Accuracy of Indocyanine Green (ICG) Fluorescence Imaging in Tenosynovial Giant Cell Tumor Surgery · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07227961recruiting PROMIS and Mobility Evaluation in Sarcoma Patients · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04635111recruiting A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04586660Phase 4 · active not recruiting Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04526704Phase 4 · completed Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06647901Phase 1/Phase 2 · recruiting Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05349643Phase 2 · completed A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT · condition mapped ALIAS · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor, Diffuse Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04731675Phase 2 · completed An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04938180Phase 2 · terminated A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03301857Phase 4 · completed Long-term Safety Follow-up of Subjects With Giant Cell Tumor of Bone Treated With Denosumab in Study 20062004 · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06331104completed Network Pharmacology Prediction: Mechanism Study of Puerarin in the Treatment of Giant Cell Tumors of Bone · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05542524completed Oral Care of Patients Treated With Anti-RANK-ligand Antibodies for a Giant Cell Tumour · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02948088completed Tenosynovial Giant Cell Tumors (TGCT) Observational Platform Project · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05813665Phase 3 · not yet recruiting A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05595603Phase 2 · recruiting Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00396279Phase 2 · completed Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04952896completed Clinical Study of Magnetic Resonance Imaging and Deep Learning of Joint Synovial Disease · condition mapped ALIAS · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor, Diffuse Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04255576Phase 1/Phase 2 · unknown Efficacy and Safety of JMT103 in Patients With Giant Cell Tumor of Bone · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00680992Phase 2 · completed Study of Denosumab in Subjects With Giant Cell Tumor of Bone · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05402865completed A Real-world Study on Patients of Unresectable Giant Cell Tumor of Bone · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02371369Phase 3 · completed Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS) · condition mapped ALIAS · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor, Diffuse Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02471716Phase 1/Phase 2 · completed Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor · condition mapped ALIAS · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor, Diffuse Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04955535completed Screening of Specific Genes for Pigmented Villous Nodular Synovitis · condition mapped ALIAS · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor, Diffuse Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04002817completed Giant Cell Tumor of the Bone in Young Patients · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03620149Phase 2 · terminated Reduced Dose-density of Denosumab for Unresectable GCTB · condition mapped ALIAS · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01643850Phase 2 · completed MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS) · condition mapped ALIAS · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor, Diffuse Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00464620Phase 2 · completed Trial of Dasatinib in Advanced Sarcomas · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01804530Phase 1 · terminated Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02673736Phase 1 · terminated A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03358212unknown Safety and Efficacy of Post-operative Denosumab Strategy for Giant Cell Tumor of Bone Treatment in China · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03259152Phase 3 · unknown Characteristics and Mechanism of Denosumab-treated Giant Cell Tumor of Bone · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02996734completed Giant Cell Tumor of the Extremities Treated With Surgery and/or Medical Treatment · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00889590Phase 2 · terminated Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT) · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01564121Phase 1/Phase 2 · terminated Study of the Effect of Zoledronate on Local Recurrence After Surgical Treatment of Giant Cell Tumors of Bone Zométa · condition mapped ONTOLOGY_EXACT · 52 trials mapped (22 active) | — | — | Giant Cell Tumor of Bone | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01261429Phase 2 · completed Study of Nilotinib Efficacy in Pigmented Villo-Nodular Synovitis/ Tenosynovial Giant Cell Tumour (PVNS/TGCT) · condition mapped ALIAS · 52 trials mapped (22 active) | — | — | Tenosynovial Giant Cell Tumor, Diffuse Type | 1 | Observed | clinicaltrials | graph → |